Hiển thị các bài đăng có nhãn muscular dystrophy. Hiển thị tất cả bài đăng
Hiển thị các bài đăng có nhãn muscular dystrophy. Hiển thị tất cả bài đăng

Thứ Sáu, 31 tháng 7, 2009

Can Viagra Really Protect Hearts of People with Muscular Dystrophy?

Duchenne muscular dystrophy is an inherited wasting disease characterized by weakness and progressive degeneration of the muscles, including the heart muscle. Beginning at the age of 2 to 6, the disease will spread from the legs and pelvis to the whole body. Most people with such disease have to use a wheelchair by the age of about 12.

The heart of the affected patients will experience problems at around the age of 10 and this could progress quickly, affecting most victims by the age of 20. Such heart disease is responsible for the death among patients with muscular dystrophy.

Conducted by Canadian researchers from the Montreal Heart Institute, a study involving mice reported on May 12, 2008 in the Proceedings of the National Academy of Sciences that anti-impotence pills Viagra might protect the heart of people with muscular dystrophy.

Sildenafil, the active ingredient in Viagra, was given to mice with an animal version of Duchenne muscular dystrophy. The doses of the drug given were comparable to those prescribed to treat erectile dysfunction in men. It improved the heart performance of the mice by cutting the levels of damage to contracting heart muscle cells.

The heart of those mice to which sildenafil were not given did not function as well as normal mice, and they were more susceptible to stress-induced cell death.

According to the researchers, the drug did improve heart performance in the mice by preventing the breakdown of a naturally occurring chemical called cyclic guanosine monophosphate (cGMP), which is involved in a number of cellular signaling pathways.

Besides Viagra, Other impotence drugs like vardenafil sold under the brand name Levitra, and tadalafil sold under the name Cialis also affect the chemical cGMP.

Developed as a heart medication, sildenafil is widely prescribed for erectile dysfunction and pulmonary hypertension. No doubt, there is a lot of information on sildenafil that shows it would be relatively safe in adults but the researchers stressed that future human trials are necessary before doctors could prescribe it for heart trouble for those affected patients.

Although the findings indicated Viagra could potentially be used to prevent or delay heart failure in children with Duchenne muscular dystrophy, the researchers felt it would be premature to give Viagra to people with such disease.

Nevertheless, it is believed that discussions have begun among health experts about possible future studies using the drug in patients with muscular dystrophy.

Thứ Sáu, 5 tháng 9, 2008

What Is The Risk Factor For Sudden Death in Patients With Myotonic Dystrophy?

When we talk about muscular dystrophy (MD), we refer it to a group of more than 30 genetic diseases characterized by progressive weakness and degeneration of the skeletal muscles that control movement.

Myotonic muscular dystrophy or in short myotonic dystrophy, being the most common form of MD, will cause a person prolonged muscle spasms, cataracts, cardiac abnormalities, and endocrine disturbances. Patients with myotonic dystrophy have long, thin faces, drooping eyelids, and a swan-like neck.

Statistics showed that approximately 1 of every 8,000 people in the United States was affected by myotonic dystrophy. The heart muscle of the people with such disease is adversely affected.

Over the period of 10 years, neurologists and cardiologists at 23 clinics studied 406 adults with myotonic dystrophy. During that period, 20 percent of the patients enrolled in the study died, one-third of them in sudden death were likely due to cardiac arrhythmia.

Cardiac arrhythmia (also known as dysrhythmia) is a condition in which abnormal electrical activity occurred in the heart. The heartbeat, either regular or irregular, may become too fast or too slow. Some arrhythmias are life threatening, which can cause cardiac arrest and sudden death. Sudden death means death occurs in a stable patient within 1 hour of the onset of symptoms.

The study carried out by the Indiana University School of Medicine found that adults having myotonic dystrophy and abnormal electrocardiograms are more than 3 times more likely to die suddenly than patients who have normal ECG, while those with atrial (upper) chamber arrthymias had a 5 times higher risk.

The researchers had identified the risk factors that predict a high risk of sudden death in people with myotonic dystrophy and their findings were published in the June 19, 2008 edition of the New England Journal of Medicine.

The report also revealed that pacemakers, commonly used to treat some forms of arrhythmia, did not help these patients prevent sudden death. However, using electrophysiological studies or by surgically implanting a cardioverter-defibrillator, doctors can guard against sudden death in patients showing this risk factor.